Consequently, new therapeutic strategies may include
testing of existing medication (eg, antiinflammatory
agents, prostaglandin inhibitors, and cyclooxygenase inhibitors)
or development of drugs targeting cytokines
and their receptors, leading to replacement of symptomatic
care by specific treatment.